申请人:HEINRICH-HEINE-UNIVERSITÄT DÜSSELDORF
公开号:US20160108031A1
公开(公告)日:2016-04-21
The invention relates to inhibitors of the NHR2 tetramerization and their use as tumor therapeutics (e.g. against acute myeloid leukemia (AML)), cytostatics, and diagnostic agents.